Suppr超能文献

鉴定链激酶中纤溶酶原结合区域,该区域是形成功能性链激酶-纤溶酶原激活物复合物所必需的。

Identification of a plasminogen binding region in streptokinase that is necessary for the creation of a functional streptokinase-plasminogen activator complex.

作者信息

Reed G L, Lin L F, Parhami-Seren B, Kussie P

机构信息

Cardiovascular Biology Laboratory, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

出版信息

Biochemistry. 1995 Aug 15;34(32):10266-71. doi: 10.1021/bi00032a021.

Abstract

Streptokinase is a plasminogen activator widely used to treat patients with myocardial infarction. However, streptokinase is not a protease, and must first bind and interact with plasminogen to form an enzymatic complex. By measuring the binding of recombinant streptokinase fragments to plasminogen, we have sought, first, to identify a plasminogen binding region in streptokinase and, second, to explore the relation between binding (via this region) and the generation of a functional streptokinase--plasminogen activator complex. Recombinant streptokinase bound in a saturable and specific manner to human Glu-plasminogen with a dissociation constant of 4.2 x 10(-10) M. Recombinant streptokinase fragments spanning amino acids 1-127 and 1-253 could not be shown to bind to Glu-plasminogen, whereas fragments spanning amino acids 1-352, 120-352, and 244-414 bound tightly to plasminogen and each fragment completely inhibited the binding of full-length streptokinase to plasminogen. Although these latter streptokinase fragments formed a complex with plasminogen, enzymatic assays indicated that none of them was capable of generating an active site. When the streptokinase region shared by these three fragments, spanning residues 244-352, was expressed, it also bound plasminogen and competitively inhibited the formation of a functional plasminogen activator complex by full-length streptokinase. Taken together, these data indicate that streptokinase binds to plasminogen with high affinity, that a primary binding region for plasminogen is located within amino acids 244-352, and that binding via this region is necessary for the generation of a functional plasminogen activator complex.

摘要

链激酶是一种广泛用于治疗心肌梗死患者的纤溶酶原激活剂。然而,链激酶不是蛋白酶,必须首先与纤溶酶原结合并相互作用以形成酶复合物。通过测量重组链激酶片段与纤溶酶原的结合,我们首先试图确定链激酶中的纤溶酶原结合区域,其次探索(通过该区域的)结合与功能性链激酶 - 纤溶酶原激活剂复合物生成之间的关系。重组链激酶以可饱和且特异的方式与人谷氨酸纤溶酶原结合,解离常数为4.2×10^(-10) M。跨越氨基酸1 - 127和1 - 253的重组链激酶片段未显示与谷氨酸纤溶酶原结合,而跨越氨基酸1 - 352、120 - 352和244 - 414的片段则紧密结合纤溶酶原,并且每个片段都完全抑制全长链激酶与纤溶酶原的结合。尽管后一种链激酶片段与纤溶酶原形成了复合物,但酶活性测定表明它们均不能产生活性位点。当表达这三个片段共有的链激酶区域(跨越残基244 - 352)时,它也结合纤溶酶原,并竞争性抑制全长链激酶形成功能性纤溶酶原激活剂复合物。综上所述,这些数据表明链激酶与纤溶酶原具有高亲和力结合,纤溶酶原的主要结合区域位于氨基酸244 - 352内,并且通过该区域的结合对于生成功能性纤溶酶原激活剂复合物是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验